|
World TB Day 2022 was held online on March 24, with over 450 people from across the US joining live. Speakers came from across the globe, including our Keynote Panelists Phumeza Tisile (South Africa), Gloriah Kerubo (Kenya), and Rhea Lobo (Denmark) who began the day sharing their experiences as TB survivors. Our keynote was moderated by Dr. Eric Goosby, with opening remarks by U.S. Representative Ami Bera.
| |
|
Our "Live with London" session connected us to University College of London for a discussion on innovative patient-centered trials. Sessions "Bringing TB Science to TB Patients" and "Sciencing Our Way Out of the TB Pandemic" brought together UCSF, UC Berkeley, and California Dept of Public Health experts.
Congratulations to our planning team Drs. Sara Suliman, Gustavo Velásquez, Devan Jaganath, and Chris Berger on a successful event. The event was co-hosted by Curry International Tuberculosis Center (you can find the recording on their website soon). Special gratitude to Drs. Payam Nahid and Lisa Chen.
| |
Inaugural Annual Center for Tuberculosis Meeting | |
|
The Center for Tuberculosis hosted its first annual meeting on March 9, 2022 at Mission Bay. Center-affiliated faculty and staff shared their input and worked together to draft the Center's mission. For many, this was our first opportunity to be present, in-person, and among colleagues in two years!
We shared our successes such as TB RAMP, and participants identified recurring themes throughout the day that will inform the Center's vision, mission, and core values. Thank you to all who attended and shared your hopes for the Center's future. The Center will announce a new mission statement and plans for a social gathering in the coming month.
| |
Hélène Aschmann, PhD
Lab of Adithya Cattamanchi, MD
Tell us about yourself and what piqued your interest in TB research?
I am currently a postdoc developing benefit-harm balance models on latent TB treatment. I did my PhD back home in Switzerland. My first contact with TB research happened by coincidence when doing my master thesis on physiologically-based pharmacokinetic modeling: I was studying isoniazid, one of the key drugs to prevent and cure TB. I was able to link the pharmacokinetic model to clinical data on the efficacy and side effects to predict better dosing strategies. In my PhD, I learned more about how to balance benefits (i.e., efficacy) against harms (i.e., side effects and treatment burden) in quantitative models and support individualized decisions. I had always planned to go back and apply these methods to TB, but it became obvious that better decision support is needed for or against preventive treatment when I was suddenly faced with the decision myself. The more I learned about guidelines on latent TB, the more I felt the need to check the benefit-harm balance with my own models and help people get more patient-centered care.
| |
|
Keystone Symposia 50th Anniversary
"A Research Reboot of TB"
Aug 1-4 | Breckenridge, CO
The Keystone "A Research Reboot of Tuberculosis" symposia has been rescheduled from its original January date to August 1-4, 2022.
Abstracts due: April 26, 2022
Registration Deadline: June 1, 2022
Global Health Award: July 21, 2022
| |  |
|
LATER THIS YEAR
ID Week
Sept 29-Oct 3 | Virtual
Submissions Due: May 4, 2022
for Abstracts and Cases
The Union
Nov 8-11 | Virtual
Submissions Due: May 4, 2022
for Abstracts, Satellite Sessions, Symposia, Post-Graduate Workshops
| |
|
Biomarker Signatures of TB Infection in Young Children With and Without HIV (R01)
Posted: February 10, 2022
Open: May 8, 2022
Learn more
Global Brain and Nervous System Disorders Research Across the Lifespan (R01)
(interaction of environmental enteropathy and infectious diseases with brain development in the fetus, infants, children and adolescents in LMIC)
Posted: February 8, 2022
Open: October 13, 2022
Learn More
| | |
|
Improved Drug Susceptibility Testing (DST) for Tuberculosis (R01)
Posted: March 2, 2022
Open: June 8, 2022
Learn more
Global Brain and Nervous System Disorders Research Across the Lifespan (R21)
(interaction of environmental enteropathy and infectious diseases with brain development in the fetus, infants, children and adolescents in LMIC)
Posted: February 9, 2022
Open: October 14, 2022
Learn More
| |
|
The Center for Tuberculosis at UCSF wants to capture every success, funded project, and publication by its faculty. If you have news to share, please fill out this survey to keep our website updated.
Please contact the Center's manager, Sarah K. Hutch, for any CTB-related needs or questions.
| | | | |
